Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
2025/12/02

DJ Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bio-Techne Corp. $(TECH)$ shed 1.16% to $63.76 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33.

This was the stock's third consecutive day of losses.

Bio-Techne Corp. closed 19.58% below its 52-week high of $79.28, which the company reached on February 5th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ fell 2.31% to $337.49, Charles River Laboratories International Inc. $(CRL)$ fell 1.15% to $176.09, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 1.61% to $55.03.

Trading volume (1.6 M) remained 721,456 below its 50-day average volume of 2.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 01, 2025 17:17 ET (22:17 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10